ArticleImmunity2016
Antiviral CD8
Open access · hybridAbstract read
In one paragraph
Article in Immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 67 citations in OpenAlex.
- Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIA.Nature communications · 2026Article
- T cell receptor cross-reactivity prediction improved by a comprehensive mutational scan database.Cell systems · 2025Article
- Comprehensive epitope mutational scan database enables accurate T cell receptor cross-reactivity prediction.bioRxiv : the preprint server for biology · 2025Article
- HIV-1 adapts to HLA class II-associated selection pressure exerted by CD4Science advances · 2025Article
- Human cytomegalovirus UL18 prevents priming of MHC-E- and MHC-II-restricted CD8Science immunology · 2024Article
- Feeder-free differentiation of human iPSCs into natural killer cells with cytotoxic potential against malignant brain rhabdoid tumor cells.Bioactive materials · 2024Article
- Current Views about the Inflammatory Damage Triggered by Bacterial Superantigens and Experimental Attempts to Neutralize Superantigen-Mediated Toxic Effects with Natural and Biological Products.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024Review
- Characterization of atypical T cells generated duringFrontiers in immunology · 2024Article
- A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design.The Journal of experimental medicine · 2023Article
- Protective HLA-B57: T cell and natural killer cell recognition in HIV infection.Biochemical Society transactions · 2022Review
- Enriching and Characterizing T Cell Repertoires from 3' Barcoded Single-Cell Whole Transcriptome Amplification Products.Methods in molecular biology (Clifton, N.J.) · 2022Article
- Human CD4 T Cells From Thymus and Cord Blood Are Convertible Into CD8 T Cells by IL-4.Frontiers in immunology · 2022Article
- Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.Frontiers in pharmacology · 2022Review
- Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2.Virusdisease · 2021Article
- Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals.Cell discovery · 2021Article
- High-throughput and single-cell T cell receptor sequencing technologies.Nature methods · 2021Review
- Article
- T-Cell Repertoire Characteristics of Asymptomatic and Re-Detectable Positive COVID-19 Patients.Frontiers in immunology · 2021Article
- Conversion of effector CD4Cellular & molecular immunology · 2021Article
- Elevated Numbers of HIV-Specific Poly-Functional CD8Frontiers in immunology · 2021Article
Corrections and comments
- Commented on by
Authors and funding
22 authors at 9 institutions in 3 countries.
Srinika RanasingheRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA. Electronic address: sranasinghe@mgh.harvard.edu.
Pedro A LamotheRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Damien Z SoghoianRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA.
Samuel W KazerRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 01239, USA; Broad Institute, Cambridge, MA 01239, USA.
Michael B ColeDepartment of Physics, University of California, Berkeley, CA 94720, USA.
Alex K ShalekRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 01239, USA; Broad Institute, Cambridge, MA 01239, USA.
Nir YosefRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Department of Physics, University of California, Berkeley, CA 94720, USA.
R Brad JonesRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; George Washington University, Washington, DC 20052, USA.
Faith DonagheyRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA.
Chioma NwonuRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA.
Priya JaniRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA.
Gina M ClaytonHoward Hughes Medical Institute, Chevy Chase, MD 20815, USA; Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA.
Frances CrawfordHoward Hughes Medical Institute, Chevy Chase, MD 20815, USA; Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA.
Janice WhiteDepartment of Biomedical Research, National Jewish Health, Denver, CO 80206, USA.
Alana MontoyaDepartment of Biomedical Research, National Jewish Health, Denver, CO 80206, USA.
Karen PowerRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA.
Todd M AllenRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA.
Hendrik StreeckInstitute for HIV Research, University Hospital, University Duisburg-Essen, Essen 45147, Germany; U.S. Military HIV Research Program, Henry M. Jackson Foundation, Rockville, MD 20910, USA.
Daniel E KaufmannRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Centre de Recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC H2X 3J4, Canada.
Louis J PickerVaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
John W KapplerHoward Hughes Medical Institute, Chevy Chase, MD 20815, USA; Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA.
Bruce D WalkerRagon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 01239, USA; Broad Institute, Cambridge, MA 01239, USA. Electronic address: bwalker@mgh.harvard.edu.
Ragon Institute of MGH, MIT and Harvard · USHoward Hughes Medical Institute · USMassachusetts Institute of Technology · USNational Jewish Health · USUniversity of Colorado Denver · USGeorge Washington University · USHenry M. Jackson Foundation · USOregon National Primate Research Center · USUniversity of California, Berkeley · US
Funding
The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4MVaccine Adjuvant/ Delivery Systems CoreP01AI104715 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2013 to 2017
$12.3M"Bottom - Up" Profiling of Interacting Cellular SystemsDP2GM119419 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHALEK, ALEX K · 2015 to 2015
$2.3MAn integrated multiplexed genomic assay for low input clinical samples1U24AI118672 · NIAID · BROAD INSTITUTE, INC. · PI SHALEK, ALEX K · 2015 to 2019
$2.0MMolecular Mechanisms of MHCII Recognition by CD8 T Cells in HIV Non-Progressor PatientsR21AI125085 · NIAID · NATIONAL JEWISH HEALTH · PI KAPPLER, JOHN W · 2016 to 2017
$436kHoward Hughes Medical InstituteNIAID NIH HHS P01 AI104715NIAID NIH HHS P30 AI060354NIAID NIH HHS R21 AI125085NIAID NIH HHS U24 AI118672NIGMS NIH HHS DP2 GM119419
Abstract
CD8
Indexed as
Antiviral AgentsCD8-Positive T-LymphocytesHistocompatibility Antigens Class IIHIV InfectionsHLA AntigensHumansReceptors, Antigen, T-Cell, alpha-betaAntiviral AgentsHistocompatibility Antigens Class IIHLA AntigensReceptors, Antigen, T-Cell, alpha-betaCD8(+) T cellsHIVHLAMHC class IITCRvaccines
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.